EUVIMEDScopri EUVIMED
Übersichtsarbeit

Trispecific antibodies for cancer immunotherapy

Yin Yao, Yiyin Hu, Fei Wang iD

Immunology · 2023-08 · 169 (4) · 389-399

DOI: 10.1111/imm.13636 ↗

At a glance

Übersichtsarbeit in Immunology, published online on 2023-03-08. Written by Yin Yao and 2 co-authors. Institution: Department of Pharmacy, Fourth People's Hospital of Gui Yang, Guiyang, China. Major MEDLINE topics: Antibodies, Bispecific, Neoplasms. Cited 40 times so far (Crossref); 67 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Despite the clinical success of monoclonal and bispecific antibodies, there are still limitations in the therapeutic effect of malignant tumours, such as low response rate, treatment resistance, and so on, inspiring the exploration of trispecific antibodies (TsAbs). TsAbs further improve the safety and efficacy and has great clinical potential through three targets combination and formats optimization. This article reviews the development history and the target combination features of TsAbs. Although there are still great challenges in the clinical application of TsAbs, it is undeniable that TsAbs may be a breakthrough in the development of antibody drugs.

Subjects

MeSH terms (MEDLINE)

Antibodies, BispecificNeoplasmsHumansImmunotherapy

Author keywords

NK cell engagerT cell engagercancer immunotherapytrispecific antibody

Substances

Antibodies, Bispecific

Authors and institutions

  • Department of Pharmacy, Fourth People's Hospital of Gui Yang, Guiyang, China.
  • Department of Nursing, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID profiles: Fei Wang

Cite

APA

Yao, Y., Hu, Y., & Wang, F. (2023). Trispecific antibodies for cancer immunotherapy. Immunology, 169(4), 389-399. https://doi.org/10.1111/imm.13636

Vancouver

Yao Y, Hu Y, Wang F. Trispecific antibodies for cancer immunotherapy. Immunology. 2023;169(4):389-399. doi:10.1111/imm.13636

BibTeX
@article{Yao2023,
  author = {Yao, Yin and Hu, Yiyin and Wang, Fei},
  title = {Trispecific antibodies for cancer immunotherapy},
  journal = {Immunology},
  year = {2023},
  volume = {169},
  number = {4},
  pages = {389--399},
  doi = {10.1111/imm.13636}
}
Start for free →